BTSG
HealthcareBrightSpring Health Services, Inc. Common Stock · Medical - Healthcare Information Services · $11B
What is BrightSpring Health Services, Inc. Common Stock?
BrightSpring Health Services operates a home and community-based healthcare platform across the United States, serving Medicare, Medicaid, and commercially insured patients through pharmacy and clinical care services. Headquartered in Louisville, Kentucky, the company focuses on keeping complex patients out of institutional settings.
BrightSpring generates revenue by delivering integrated pharmacy and provider services to patients in home and community settings. Its clinical teams and pharmacists support individuals with complex medical needs — including behavioral health, disabilities, and chronic conditions — who would otherwise require facility-based care. The business model centers on value-based, lower-cost alternatives to hospital or nursing-home care, contracting primarily with government payers like Medicare and Medicaid alongside commercial insurers.
The company traces its roots to 1974 and is based in Louisville, Kentucky.
- Home-based pharmacy services for complex patients
- Community-based clinical and supportive care
- Behavioral health and disability support services
- Provider services for Medicare and Medicaid populations
Is BTSG a Good Stock to Buy?
UQS Score rates BTSG as Below Average overall, reflecting meaningful structural challenges alongside a standout growth profile.
The Growth pillar is the clearest bright spot for BrightSpring — the company is expanding its revenue base at a pace that stands out relative to many healthcare peers. That top-line momentum reflects genuine demand for home-based care alternatives as the U.S. healthcare system shifts away from costly institutional settings.
The Quality, Moat, and Risk pillars all register as Weak, pointing to thin profitability, limited competitive differentiation, and a balance sheet that warrants close attention from investors.
See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does BTSG pay dividends?
No — BrightSpring Health Services, Inc. Common Stock does not currently pay a dividend.
BrightSpring does not currently pay a dividend. Given the company's growth-oriented strategy and the capital demands of scaling a home-based care platform, available cash is directed toward operational expansion and debt management rather than shareholder distributions. Income-focused investors should factor this into their assessment.
When does BTSG report earnings?
BrightSpring Health Services reports earnings on a quarterly cadence, consistent with standard practice for US-listed equities.
Revenue growth has been a consistent theme in recent reporting periods, driven by expansion across pharmacy and provider service lines. However, profitability metrics have remained under pressure, reflecting the cost structure of operating at scale in government-reimbursed care markets.
For the most recent quarter's results and guidance, visit BrightSpring Health Services' investor relations page directly.
BTSG Price History
+318.3% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in BrightSpring Health Services, Inc. Common Stock?
Based on BrightSpring Health Services, Inc. Common Stock's historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
BTSG Long-term Outlook
BrightSpring's Strong Growth pillar suggests the company's top-line trajectory remains one of its most compelling attributes. Demand for home and community-based care is structurally supported by an aging population and ongoing policy pressure to reduce institutional healthcare costs. That said, the Weak Risk pillar introduces meaningful uncertainty — leverage levels and reimbursement rate exposure could weigh on the path to sustainable profitability. The Neutral Valuation pillar suggests the market has partially priced in both the growth opportunity and the execution risk.
Growth drivers
- Aging U.S. population increasing demand for home-based care
- Government policy favoring lower-cost community care alternatives
- Cross-selling pharmacy and provider services to existing patients
Key risks
- Heavy reliance on Medicare and Medicaid reimbursement rates
- Elevated debt load limiting financial flexibility
- Thin margins leaving little buffer for operational disruptions
BTSG vs Peers
BrightSpring operates in a broad healthcare services landscape that includes technology-enabled platforms and digital health companies targeting overlapping patient populations.
Tempus AI focuses on AI-driven clinical data and precision medicine, contrasting with BrightSpring's hands-on home care delivery model.
HealthEquity operates health savings account infrastructure, serving a commercially insured population rather than BrightSpring's Medicaid-heavy base.
Doximity provides a physician networking and telehealth platform, competing for healthcare engagement dollars rather than direct patient care delivery.
Frequently Asked Questions
What does BrightSpring Health Services do?
BrightSpring delivers home and community-based healthcare services across the United States. Its platform combines pharmacy services with clinical and supportive care, primarily for patients covered by Medicare, Medicaid, or commercial insurance who have complex or chronic health needs.
Does BTSG pay dividends?
No, BrightSpring Health Services does not currently pay a dividend. The company is in a growth phase and directs capital toward expanding its service platform and managing its debt obligations rather than returning cash to shareholders.
When does BTSG report earnings?
BrightSpring reports financial results on a quarterly basis, in line with standard US public company practice. For exact dates and the most recent results, check the investor relations section of the company's official website.
Is BTSG a good stock to buy?
UQS Score rates BTSG as Below Average overall. While the Growth pillar is Strong, the Quality, Moat, and Risk pillars are all Weak — meaning investors should weigh the top-line expansion story against real concerns around profitability and financial risk. The full pillar breakdown is available to Pro members.
Is BTSG overvalued?
The UQS Valuation pillar for BTSG is rated Neutral, suggesting the current market price is neither clearly cheap nor obviously expensive relative to the company's fundamentals. Investors should consider the weak quality and risk profile when assessing whether that valuation is justified.
How does BTSG compare to its competitors?
BrightSpring differs from peers like Tempus AI, HealthEquity, and Doximity in that it operates a direct patient care delivery model rather than a technology or financial platform. Its government-payer focus and home-care model create a distinct but lower-margin competitive position compared to higher-multiple digital health peers.
What is BTSG's market cap bracket?
BrightSpring Health Services is classified as a mid-cap company. This places it in a segment of the market that can offer growth potential but may carry more volatility and less analyst coverage than large- or mega-cap healthcare names.
Who founded BrightSpring Health Services?
The company traces its origins to 1974 and was formerly known as Phoenix Parent Holdings Inc. before rebranding as BrightSpring Health Services in May 2021. For detailed founding history, the company's official investor relations materials are the most reliable source.
Is BTSG a long-term quality investment?
As a long-term quality indicator, UQS rates BTSG as Below Average. The Strong Growth pillar is encouraging, but sustained long-term quality typically requires stronger profitability, a durable competitive moat, and a manageable risk profile — areas where BrightSpring currently scores Weak.
What is the main competitive advantage of BrightSpring?
BrightSpring's scale in home and community-based care — combining pharmacy and clinical services under one platform — gives it operational breadth that smaller providers struggle to replicate. However, the UQS Moat pillar rates this advantage as Weak, reflecting limited pricing power and high reimbursement dependency.
What sector does BTSG belong to?
BrightSpring Health Services operates in the Healthcare sector, specifically within home health and pharmacy services. It serves a government-payer-heavy patient population, making it sensitive to Medicaid and Medicare policy changes.
Is BTSG a growth stock or value stock?
Based on UQS pillar labels, BTSG leans toward growth — the Growth pillar is rated Strong while Valuation is Neutral. It does not fit the classic value profile given its weak profitability metrics, but it also lacks the premium valuation typically associated with high-quality growth stocks.
Unlock Full BTSG Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the complete five-pillar UQS Score breakdown
- ✓Access detailed financial metrics and trend data
- ✓Compare BTSG against sector peers side by side
- ✓Screen for stocks with stronger Quality and Moat scores
- ✓Get the full analyst view available to Pro members
Pro Analysis
BTSG — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 23, 2026 | 44.4 | 38.2 | 28.0 | 82.9 | 24.1 | 51.3 | -0.1 |
| May 22, 2026 | 44.5 | 38.2 | 28.0 | 82.9 | 24.1 | 51.5 | +0.1 |
| May 21, 2026 | 44.4 | 38.2 | 28.0 | 82.9 | 24.1 | 51.3 | -0.2 |
| May 20, 2026 | 44.6 | 38.2 | 28.0 | 82.9 | 24.1 | 52.1 | 0.0 |
| May 19, 2026 | 44.6 | 38.2 | 28.0 | 82.9 | 24.1 | 52.3 | +0.1 |
| May 16, 2026 | 44.5 | 38.2 | 28.0 | 82.9 | 24.1 | 51.6 | 0.0 |
| May 15, 2026 | 44.5 | 38.2 | 28.0 | 82.9 | 24.1 | 51.3 | -0.1 |
| May 14, 2026 | 44.6 | 38.2 | 28.0 | 82.9 | 24.1 | 52.2 | 0.0 |
| May 13, 2026 | 44.6 | 38.2 | 28.0 | 82.9 | 24.1 | 52.6 | -0.1 |
| May 12, 2026 | 44.7 | 38.2 | 28.0 | 82.9 | 24.1 | 52.8 | 0.0 |
BTSG — Pillar Breakdown
Quality
— 38.2/100 (25%)BrightSpring Health Services, Inc. Common Stock has average quality metrics, with room for improvement in margins or capital efficiency.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 82.9/100 (20%)BrightSpring Health Services, Inc. Common Stock is growing rapidly with strong revenue and earnings expansion.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 24.1/100 (15%)BrightSpring Health Services, Inc. Common Stock presents elevated risk with concerns around leverage or financial stability.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 52.0/100 (15%)BrightSpring Health Services, Inc. Common Stock has a mixed valuation — some metrics suggest fair value while others appear stretched.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 28/100 (25%)BrightSpring Health Services, Inc. Common Stock operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for BTSG.
Score Composition
Financial Data
More Stock Analysis
How is the BTSG UQS Score Calculated?
The UQS (Unified Quality Score) for BrightSpring Health Services, Inc. Common Stock is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses BrightSpring Health Services, Inc. Common Stock's competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether BrightSpring Health Services, Inc. Common Stock is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.